Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists.

about

Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists.

Item

http://www.wikidata.org/entity/Q48550627

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Standardized assessment of tum ...... greement between pathologists.

@en

Standardized assessment of tum ...... greement between pathologists.

@nl

type

Item

label

Standardized assessment of tum ...... greement between pathologists.

@en

Standardized assessment of tum ...... greement between pathologists.

@nl

prefLabel

Standardized assessment of tum ...... greement between pathologists.

@en

Standardized assessment of tum ...... greement between pathologists.

@nl

P1476

Standardized assessment of tum ...... greement between pathologists.

@en

P2093

Anne-Marie B Jylling

http://www.w3.org/2001/XMLSchema#string

Anne-Vibeke Lænkholm

http://www.w3.org/2001/XMLSchema#string

Emmanouela Vouza

http://www.w3.org/2001/XMLSchema#string

Giedrius Lelkaitis

http://www.w3.org/2001/XMLSchema#string

Péter Ragó

http://www.w3.org/2001/XMLSchema#string

Scientific Committee of Pathology, Danish Breast Cancer Group (DBCG)

http://www.w3.org/2001/XMLSchema#string

Tina Di Caterino

http://www.w3.org/2001/XMLSchema#string

Tomasz P Tabor

http://www.w3.org/2001/XMLSchema#string

Trine Tramm

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study

Interrater agreement and interrater reliability: key concepts, approaches, and applications.

The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial

Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions.

Clinical relevance of host immunity in breast cancer: from TILs to the clinic.

P304

90-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1403040

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maj-Lis Møller Talman

P577

2017-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29168428

http://www.w3.org/2001/XMLSchema#string